Stryker (SYK) Liabilities and Shareholders Equity (2009 - 2026)

Stryker's (SYK) quarterly Liabilities and Shareholders Equity came in at $46.3 billion in Q1 2026, up 55008.33% year-on-year from N/an in Q1 2025, and down 3.25% on a QoQ basis from $47.8 billion in Q4 2025.

Stryker (SYK) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Stryker (SYK) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $46.3 billion in Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 55008.33% year-over-year to $46.3 billion in Q1 2026; TTM through Mar 2026 was $187.5 billion, a 335.02% increase from a year earlier, with the FY2025 full-year figure at $47.8 billion, up 11.34% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $46.3 billion, down from $47.8 billion in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for SYK reached as high as $47.8 billion in Q4 2025 and fell as low as $1.0 million in Q3 2023.
  • Historically, Liabilities and Shareholders Equity has averaged $28.8 billion across 5 years, with a median of $36.8 billion in 2023.
  • Across the five-year window, Liabilities and Shareholders Equity tumbled 100.0% in 2023 and soared 180888.46% in 2025, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $36.9 billion in 2022, then rose by 8.21% to $39.9 billion in 2023, then increased by 7.66% to $43.0 billion in 2024, then grew by 11.34% to $47.8 billion in 2025, then decreased by 3.25% to $46.3 billion in 2026.
  • Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $46.3 billion in Q1 2026, $47.8 billion in Q4 2025, and $47.1 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 184.16 Bn 176.87 Bn 6.27 Bn 110.43 Bn
2 Stryker 128.86 Bn 125.98 Bn 3.81 Bn 46.29 Bn
3 Medtronic 108.89 Bn 99.67 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 68.54 Bn 67.08 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 47.44 Bn 43.76 Bn 1.29 Bn 13.32 Bn
6 GE HealthCare Technologies 28.45 Bn 26.16 Bn 1.98 Bn 37.13 Bn
7 Dexcom 28.36 Bn 27.24 Bn 750.30 Mn 6.63 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - 10.46 Bn
9 Koninklijke Philips 25.54 Bn 22.42 Bn 2.07 Bn 31.92 Bn
10 Steris 21.57 Bn 21.13 Bn 697.10 Mn 10.74 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 46.29 Bn
Dec 31, 2025 47.84 Bn
Sep 30, 2025 47.06 Bn
Jun 30, 2025 46.33 Bn
Mar 31, 2025 84.00 Mn
Dec 31, 2024 42.97 Bn
Sep 30, 2024 26.00 Mn
Jun 30, 2024 26.00 Mn
Mar 31, 2024 26.00 Mn
Dec 31, 2023 39.91 Bn
Sep 30, 2023 1.00 Mn
Jun 30, 2023 37.41 Bn
Mar 31, 2023 36.83 Bn
Dec 31, 2022 36.88 Bn
Sep 30, 2022 35.98 Bn
Jun 30, 2022 36.03 Bn
Mar 31, 2022 36.14 Bn
Dec 31, 2021 34.63 Bn
Sep 30, 2021 34.15 Bn
Jun 30, 2021 33.70 Bn